Pyeazolam

Pyeazolam (SH-TRI-108) is a triazolobenzodiazepine derivative which has been sold online as a designer drug. It has been found to be relatively selective for the α5 subtype of GABAA receptors, in a similar manner to the related compound QH-ii-066, and is claimed to have an effects profile more similar to alcohol than typical benzodiazepines.

Several possible routes for synthesis have been determined.